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OBJECTIVES: Appetite loss, a common symptom in cancer patients, contributes to worsened nutritional status.
A validated specific tool to assess appetite is clinically useful for diagnosing and identifying symptoms and signs
that could be reversed with nutritional and pharmacological therapies. The aim of this study is to produce a
Brazilian Portuguese version of the Hill and Blundell visual analog scale (VAS) for appetite and investigate its
validity among hospitalized cancer patients.
METHODS: The original English VAS version was translated into Brazilian Portuguese in full accordance with the
guidelines in the literature and adapted to the Brazilian context by conducting interviews and meetings with an
expert committee until the final version was reached. Afterwards, the version was validated in hospitalized
cancer patients in a cross-sectional study at Sa˜o Paulo Cancer Institute (ICESP), where the relationships between
breakfast intake (rest-ingestion index) and VAS were compared. The Spearman test was used to verify the
correlation between the rest-ingestion index and the VAS ratings.
RESULTS: Sixty-four patients with a mean age of 56.1 (±12.3) years answered the Portuguese VAS version, and
their breakfast intake was evaluated. The mean rest-ingestion index was 18.8%. The correlations between the
rest-ingestion index (food acceptance) and three questions of the Portuguese visual analog scale version were
inverse and significant: first question (r -0.3028 p=0.0046), second question (r -0.2317 p=0.0319) and third
question (r -0.3049 p=0.0043).
CONCLUSION: The ‘‘Appetite Assessment Scale of Brazilian Oncology Patients’’ is a valid instrument to assess
appetite in hospitalized cancer patients in Brazil.
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’ INTRODUCTION
Loss of appetite is common in cancer patients and can
occur, among other factors, due to changes in the central
nervous system and peripheral neurohormonal signs that
govern appetite (1,2).
The incidence rates in patients with advanced cancer can
range from 39.0% to 81.5% for weight loss and 30.0% to
80.0% for anorexia (3). Lack of appetite was reported by
80.0% of patients in palliative care (4). This broad variation
reflects conditioning factors such as distinct assessment
patterns, selection of different clinical populations (stages
of cancer) and inconsistent methodologies including retro-
spective analysis of medical records, cross-sectional assess-
ments and longitudinal designs.
There is an association between lack of appetite and
radiotherapy. In patients with head and neck cancer, the
amount of irradiation was related to the worsening of
appetite. At 20 Gy of radiation, a lack of appetite was
associated with lower sensitivity to taste. With a higher
frequency (50 Gy), lack of appetite was associated with
oral mucositis, dry mouth, low saliva production in the
morning, reduction in taste sensitivity, analgesic use and
frequency of oral care (5).
Loss of appetite was present in 64.0% of patients with
gastroesophageal cancer. The highest intensity of appetite
loss was associated with tumor size, staging, the impossi-
bility of surgical treatment, weight loss, and dysphagia (6).
Similarly, in esophageal cancer patients, there is an associa-
tion between loss of appetite and worse survival rates (7,8).
Difficulties in the diagnosis of anorexia and the identifica-
tion of anorexia-cachexia syndrome (SAC) lead to detri-
mental consequences for patients’ nutritional status (9). SAC
is characterized by weight loss (5.0% or greater) andDOI: 10.6061/clinics/2019/e1257
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inflammatory and metabolic abnormalities that include
changes in the intermediary metabolism of carbohydrates,
lipids and proteins (10).
Due to the high prevalence of appetite loss in cancer
patients, it is of interest to have a specific tool to assess
appetite and diagnose and identify the symptoms and signs
that can be reversed with nutritional and pharmacological
therapeutic strategies. The proper detection of appetite loss
helps in the early indication of specific dietary and phar-
macological measures (11). However, the measurement of
appetite is challenging because it is subjective and experi-
enced differently by each individual.
In clinical studies, appetite is often assessed using visual
analog scales (VASs), which record subjective sensations, such
as hunger and fullness. The use of VASs has been particularly
popular for the assessment of pain and appetite (12).
According to studies that have evaluated appetite, VASs
are sensitive to several types of experimental manipulations,
including changes in diet composition (13,14), changes in
energy intake (15) and administration of drugs that stimulate
or inhibit appetite (16).
In Brazil, there are no records of validated scales for the
evaluation of appetite among cancer patients. Awidely used
validated version is beneficial for conducting clinical and
epidemiological research on this topic and for use in clinical
practice. Thus, this study was performed with the objective
of producing a Brazilian Portuguese version of the Hill and
Blundell VAS for the assessment of appetite and to investi-
gate its validity.
’ METHODS
This study was conducted at São Paulo Cancer Institute
(ICESP) in Brazil from January to September 2013. The
project was approved by the Research Ethics Committee of
the Faculty of Medicine of São Paulo University (CEP-
FMUSP) (protocol no 6639).
The present study consisted of two parts: translation and
validation.
The VAS developed by Hill & Blundell (1982) was chosen
because it is a nonextensive scale, easy to understand,
complete and used/validated in other languages (12,14,17-
21). It is a VAS with five questions. On each 100-mm line, an
appetite sensation is paired with the opposing sensation (for
example, ‘hungry’ and ‘not hungry’).
Translation
Four independent translators (native Brazilians), including
three health professionals (nutritionists) and one English
teacher, translated the VAS from English into Brazilian
Portuguese. A synthesis of the translations was agreed upon
by consensus between translators (V1). Eleven participants
were interviewed to verify their comprehension of V1. Those
patients completed the scale with assistance: questions were
read aloud by the interviewer. Participants were asked about
their understanding of the scale and were invited to offer
suggestions that could clarify its meaning. An expert
committee reviewed all of the reports and reached consensus
on a new version (V2).
Four independent native English speakers who fluently
speak Brazilian Portuguese created a back translation into
English. The translators were blinded to the original version.
The back translations were synthesized by consensus between
translators (V3) and were compared with the original version
of the scale to verify the reliability. The main authors (Hill and
Blundell) examined this combined version and gave consent
for its use.
Finally, based on the consensus of the researchers and
a multiprofessional nutritional therapy team from ICESP,
the final version in Brazilian Portuguese was created (Version
4 - Appetite Assessment Scale of Brazilian Oncology Patients
‘‘EAA-BR’’–‘‘Escala Avaliac¸ão Apetite em Pacientes Oncoló-
gicos Brasileiros’’) (Figure 1).
Validation of the EAA-BR
To perform the validation of the EAA-BR, a preliminary
cross-sectional study was performed in clinically and
surgically hospitalized patients from August to September
2013. The inclusion criteria were 18 years of age or older,
conscious and guided state according to the nursing team
(Glasgow 15, Richmond Agitation-Sedation Scale (RASS) 0
and negative Confusion Assessment Method (CAM)), con-
sumption of an exclusively oral diet (normal or soft) and
ability to provide meaningful informed consent.
Exclusion criteria were the use of enteral or parenteral
nutrition, reduced level of consciousness or severe psychia-
tric illness, aerosol or contact isolations, inability to perceive
taste after partial or total glossectomy, presence of brain
tumor or cranial trauma, severe pain that could interfere
with food intake, dysphagia and inability to understand the
questions of the VAS.
Data on age, sex, oncological diagnosis, reason and length
of hospital stay, body mass index (BMI) and presence of
weight loss X5% in the last 3 months (prior to admission)
were collected from the electronic medical chart. The use of
corticosteroids within two days prior to the interview date
was verified.
Figure 1 - (a) Original visual analog scale; (b) Appetite Assessment Scale of Brazilian Oncology Patients ‘‘EAA-BR’’.
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Nutritional Risk Screening - 2002 (NRS-2002) (22) and
Global Subjective Assessment (ASG) (23) were used to assess
nutritional risk and nutritional status, respectively. BMI
was classified according to the World Health Organization
proposal (24) for individuals aged up to 60 years and
according to the Pan American Health Organization (25) for
individuals aged 60 years and over.
To validate the EAA-BR, it was compared in relation to the
amount of food effectively ingested by the patient during
breakfast. The application of the appetite scale (EAA-BR)
was performed before the meal, and the total amount of food
consumed at the test meal was measured by weighing food
items before and after eating to the nearest 1 g (Dayhomes,
Sao Paulo, SP). The rest-ingestion index was calculated
according to the following formula: rest-ingestion index (%) =
(quantity rejected (g) / quantity offered (g)) x 100 (26).
For descriptive analysis, quantitative variables were pre-
sented as the mean and standard deviation. The Shapiro-
Wilk test was used to assess normality. For the variables
that were not normally distributed, the Spearman test was
used to verify the correlation between the rest-ingestion
index and the EAA-BR ratings. Significance was accepted
at the level of po0.05. Those older than 60 years were
considered elderly.
’ RESULTS
Sixty-four patients were evaluated. The mean age was
56.1 (±12.3) years; 52.3% were females. Gynecological
cancer (29.7%) was the most prevalent, followed by
malignant gastrointestinal tumors (21.9%) and urological
tumors (21.9%). The majority (88.4%) either received or
were receiving some type of cancer treatment during data
collection (Table 1).
The use of corticosteroids was present in 31.3% of patients.
One-fourth of the patients (25.6%) had significant weight loss
(X5%) in the last 3 months prior to admission. Cancer
treatment was the main reason for hospital admission,
with surgical reasons being the most prevalent (80.7%). The
second reason for hospitalization was related to the presence
of symptoms, including headache, dyspnea, paresthesia,
nausea, vomiting, hyperkalemia, diarrhea, weakness, vaginal
bleeding, hypoxemia/hemoptysis, mental confusion, dizzi-
ness, among others. The mean hospital stay until the inter-
view was 5.7±6.5 days, with a total hospitalization time of
11.2±11.5 days (Table 1).
The mean BMI was 26.6±7.0 kg/m2, and 51.6% were
classified as eutrophic (Table 2).
The mean rest-ingestion index was 18.8%. Among the
patients who consumed less than 50% of the food offered,
the most reported reasons for not accepting were lack of
appetite (17%), nausea/vomiting (15%) and amount of food
offered (15%).
The correlation between the rest-ingestion index and food
acceptance was inverse and significant for three questions:
the first question (r -0.3028 p=0.0046), the second question
(r -0.2317 p=0.0319) and the third question (r -0.3049
p=0.0043) (Table 3).
’ DISCUSSION
There were no validated questionnaires for the assessment
of appetite in Brazilian Portuguese. This study demonstra-
ted that the EAA-BR is a valid and acceptable measure for
assessing appetite in Brazilian cancer patients.
The rest-intake index revealed different results from those
of the study by Ferreira et al. (26). According to these
authors, the rest-lunch intake index was 37.0% and sig-
nificantly higher among the undernourished patients, as
detected by the Subjective Global Assessment (PG-SGA)
(p=0.004). A likely explanation is that, at breakfast, patients
have greater food acceptance because of night fasting.
Table 1 - Sociodemographic and clinical characteristics of the
study sample.
n %
Sex
Male 29 45.3
Female 35 54.7
Age
Adult 43 67.2
Elderly 21 32.8
Cancer type
Gastroenterology 14 21.9
Lung 4 6.3
Urology 14 21.9
Gynecology 19 29.7
Head and neck 4 6.3
Others 9 14.1
Stage
II 14 21.9
III 8 12.5
IV 41 64.1
not applicable 1 1.6
Main reasons for hospitalization
Treatment 24 37.5
Symptoms 18 28.1
Pain 13 20.3
Infection 4 6.3
Others 5 7.8
Corticoids
Yes 20 31.3
No 44 68.8
Table 2 - Nutritional characteristics of the patients.
n %
Nutritional screening* (NRS 2002)
No nutritional risk 36 56.25
Nutritional risk 28 43.75
Subjective global assessment (Desk 1987)
Nourished 16 57.1
Moderate malnourished 12 42.9
Body mass index (BMI)
Low weight 7 10.9
Eutrophic 33 51.6
Overweight 12 18.8
Obesity 12 18.8
Table 3 - Correlation between EAA-BR scores and rest-ingestion
index of patients.
Breakfast Median (DP) RHO p
Question 1 6.22 (2.71) -0.3028 0.0046
Question 2 5.78 (2.92) -0.2317 0.0319
Question 3 5.74 (2.79) -0.0949 0.3847
Question 4 7.53 (2.42) -0.3049 0.0043
Question 5 4.25 (2.53) -0.0681 0.5335
Spearman’s test.
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In addition, breakfast foods, in general, do not produce
odors, which could cause nausea (26).
As reported by Ferreira et al., an excessive amount of food
offered was one of the reasons for not accepting the meal
(26). In addition, they described lack of appetite (26%), lack
of flavor (40.0%) and monotony of preparations (33.0%) as
reasons for not accepting the diet. Decreased food intake
may also occur due to changes in general habits, hospital
environment and dissatisfaction with dietary preparations.
Food offered in hospitals is commonly judged as insipid,
tasteless, cold, and served early. Patients hospitalized at
ICESP (unpublished data) routinely evaluate the quality of
the meals offered as excellent in terms of temperature, flavor
and mealtime. This result was obtained from quality question-
naires regarding the service itself.
Flint et al. (27) evaluated the reproducibility, power and
validity of the Blundell VAS (1982). As in our study, they
compared the VAS score against single meal intake. All VAS
questions were correlated with subsequent energy intake,
which is partially in agreement with our observations. In our
study, there was a negative correlation between the three
questions of the EAA-BR and subsequent food consumption,
that is, the lower the appetite, the greater the rest-ingestion
index.
The scores of two questions (‘‘How thirst do you feel?’’
and ‘‘How full do you feel?’’) did not show a significant
association with food acceptance or the rest-ingestion index.
A possible explanation for our findings is that some patients
reported drinking water prior to completing the question-
naire, which could have influenced their perception of thirst
and difficulty in understanding the question ‘‘How full do
you feel?’’, which may have influenced patients’ response
to the question. This paper had some limitations. First, only a
small number of patients were evaluated. Second, the mea-
sure of rest-ingestion from only one daily meal (breakfast)
can be considered as a bias and should be repeated with
lunch and dinner.
It is of interest to carry out new studies with a greater
number of patients and applying the EAA-BR to other meals
and on subsequent days.
The EAA-BR appears to be sensitive for the assessment of
appetite, presenting a significant correlation between ques-
tions about the food cravings, hunger, and prospective food
consumption and dietary intake of cancer patients. The EAA-
BR can be used routinely by health professionals for the quick
and effective identification of the level of appetite of patients.
’ CONCLUSION
The culturally adapted version of Blundel’s original English
tool (1982) in Brazilian Portuguese (EAA-BR) demonstrated
good validity compared with rest-ingestion measures when
applied to cancer patients. This questionnaire could be a useful
tool for evaluating appetite in Brazilian cancer patients in
future studies.
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